Skip to content
TrialScanner

NCT03729596

MGC018 With or Without MGA012 in Advanced Solid Tumors

Phase 1/Phase 2TerminatedMGNXLead

Registry record

Lead sponsor
MacroGenics
Conditions
Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Cancer; Melanoma; Advanced Solid Tumor, Adult; Metastatic Castrate Resistant Prostate Cancer
Primary completion
Mar 18, 2023Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03729596 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03729596: MGC018 With or Without... | TrialScanner